July 02, 2001
CURIS INC (CRIS)
form 8-K
ITEM 5. OTHER EVENTS.
On June 29, 2001, Curis, Inc. entered into a
purchase and sale agreement with Micromet, AG,
a German corporation, pursuant to which Curis
assigned its single-chain-polypeptide technology
to Micromet in exchange for approximately
U.S.$14 million in a combination of cash, equity
of Micromet, and a promissory note convertible
into the equity of Micromet.
In addition, on June 29, 2001, Curis entered into
a letter of intent with Micromet pursuant to which
the parties agreed to enter into a target research
and license agreement and a development
agreement. It is intended that these agreements
will provide Curis with royalties on Micromet's
product revenues, if any, arising out of the
assigned technology, joint ownership of future
product discoveries, if any, arising out of the
collaboration, and access by Curis to Micromet's
proprietary single cell analysis of gene expression
technology.
A copy of the purchase and sale agreement is
filed as Exhibit 2.1 to this Report and is
incorporated herein by reference. A copy of the
letter of intent is filed as Exhibit 99.1 to this
Report and is incorporated herein by reference |
